Tokyo, Japan

Chiaki Ono

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Chemical Industrial Co., Ltd.. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chiaki Ono: Innovator in Phosphine Transition Metal Complexes

Introduction

Chiaki Ono is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of chemistry, particularly in the development of phosphine transition metal complexes. Her innovative work has the potential to impact various applications, including anticancer agents.

Latest Patents

Chiaki Ono holds a patent for a phosphine transition metal complex, which is represented by a specific formula. This complex is produced through a method that involves reacting phosphine derivatives with salts of transition metals such as gold, copper, or silver. The patent highlights the unique properties of the complex and its potential use as an anticancer agent.

Career Highlights

Ono's career has been marked by her dedication to research and innovation in the chemical industry. She is currently associated with Nippon Chemical Industrial Co., Ltd., where she continues to explore new chemical compounds and their applications. Her work has garnered attention for its scientific rigor and practical implications.

Collaborations

Chiaki Ono collaborates with esteemed colleagues, including Kazuhiro Nakatsui and Nobuhiko Oohara. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the field of chemistry.

Conclusion

Chiaki Ono's contributions to the development of phosphine transition metal complexes exemplify her innovative spirit and commitment to scientific advancement. Her work not only enriches the field of chemistry but also holds promise for future applications in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…